Vadlapudi AD - Search Results

1

Ocular toxicity from systemically administered xenobiotics.

Gokulgandhi MR, Vadlapudi AD, Mitra AK. Gokulgandhi MR, et al. Among authors: vadlapudi ad. Expert Opin Drug Metab Toxicol. 2012 Oct;8(10):1277-91. doi: 10.1517/17425255.2012.708337. Epub 2012 Jul 18. Expert Opin Drug Metab Toxicol. 2012. PMID: 22803583 Free PMC article. Review.

2

Role of membrane transporters and metabolizing enzymes in ocular drug delivery.

Vadlapatla RK, Vadlapudi AD, Pal D, Mitra AK. Vadlapatla RK, et al. Among authors: vadlapudi ad. Curr Drug Metab. 2014;15(7):680-93. doi: 10.2174/1389200215666140926152459. Curr Drug Metab. 2014. PMID: 25255873 Review.

3

Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents.

Vadlapudi AD, Vadlapatla RK, Mitra AK. Vadlapudi AD, et al. Recent Pat Antiinfect Drug Discov. 2012 Apr;7(1):8-18. doi: 10.2174/157489112799829765. Recent Pat Antiinfect Drug Discov. 2012. PMID: 22044356 Free PMC article. Review.

4

Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.

Vadlapudi AD, Vadlapatla RK, Mitra AK. Vadlapudi AD, et al. Recent Pat Antiinfect Drug Discov. 2013 Apr;8(1):55-67. doi: 10.2174/1574891x11308010011. Recent Pat Antiinfect Drug Discov. 2013. PMID: 23331181 Free PMC article. Review.

5

Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery.

Vadlapudi AD, Vadlapatla RK, Mitra AK. Vadlapudi AD, et al. Curr Drug Targets. 2012 Jun;13(7):994-1003. doi: 10.2174/138945012800675650. Curr Drug Targets. 2012. PMID: 22420308 Free PMC article. Review.

6

Novel strategies for anterior segment ocular drug delivery.

Cholkar K, Patel SP, Vadlapudi AD, Mitra AK. Cholkar K, et al. Among authors: vadlapudi ad. J Ocul Pharmacol Ther. 2013 Mar;29(2):106-23. doi: 10.1089/jop.2012.0200. Epub 2012 Dec 5. J Ocul Pharmacol Ther. 2013. PMID: 23215539 Free PMC article. Review.

7

Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity.

Vadlapudi AD, Vadlapatla RK, Earla R, Sirimulla S, Bailey JB, Pal D, Mitra AK. Vadlapudi AD, et al. Pharm Res. 2013 Aug;30(8):2063-76. doi: 10.1007/s11095-013-1059-7. Epub 2013 May 9. Pharm Res. 2013. PMID: 23657675 Free PMC article.

8

Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Vadlapatla RK, Vadlapudi AD, Mitra AK. Vadlapatla RK, et al. Among authors: vadlapudi ad. Curr Drug Targets. 2013 Jul;14(8):919-35. doi: 10.2174/13894501113149990015. Curr Drug Targets. 2013. PMID: 23701276 Free PMC article. Review.

9

Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.

Vadlapudi AD, Cholkar K, Vadlapatla RK, Mitra AK. Vadlapudi AD, et al. J Ocul Pharmacol Ther. 2014 Feb;30(1):49-58. doi: 10.1089/jop.2013.0157. Epub 2013 Nov 5. J Ocul Pharmacol Ther. 2014. PMID: 24192229 Free PMC article.

10

Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.

Cholkar K, Patel A, Vadlapudi AD, Mitra AK. Cholkar K, et al. Among authors: vadlapudi ad. Recent Pat Nanomed. 2012;2(2):82-95. doi: 10.2174/1877912311202020082. Recent Pat Nanomed. 2012. PMID: 25400717 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page